SPL 5.71% 9.9¢ starpharma holdings limited

TGA interim decision re Astodrimer sodium nasal spray this week, page-2

  1. 3,516 Posts.
    lightbulb Created with Sketch. 837
    Any chance of an apology to the forum for this blatantly false claim from yesterday?…

    ‘We know that DEP has been effective in Pancreatic cancer Phase 3 trials so maybe DEP is assisting minimising adverse effects of chemotherapy’
    ~ @Starlink

    A complete fabrication!
    None of Starpharma’s DEP candidates have ever progressed to Phase 3. Ever.

    In fact, all three Starpharma partnered trials with AstraZeneca were terminated during Phase One.
    Last edited by sarge17: 26/03/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
-0.006(5.71%)
Mkt cap ! $41.39M
Open High Low Value Volume
10.5¢ 10.5¢ 9.9¢ $23.28K 232.2K

Buyers (Bids)

No. Vol. Price($)
1 25000 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 183364 5
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.